0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Cataract Formation after Bone Marrow Transplantation

Andre Tichelli, MD; Alois Gratwohl, MD; Thomas Egger, MD; Jakob Roth, MD, PhD; Alexandra Prunte, MD; Catherine Nissen, MD; and Bruno Speck, MD
[+] Article and Author Information

From the University Hospitals, Basel, Switzerland. Requests for Reprints: Andre Tichelli, MD, Hamatologische Abteilung, Departement Innere Medizin, Petersgraben 4, CH-4031 Basel, Switzerland. Acknowledgments: The authors thank Anita Nadolny and Ann Barbara Maerki for help in preparing the manuscript. Grant Support: In part by the Swiss National Science Foundation (grant 32-31316.91).


Copyright 2004 by the American College of Physicians


Ann Intern Med. 1993;119(12):1175-1180. doi:10.7326/0003-4819-119-12-199312150-00004
Text Size: A A A

Objective: To evaluate the incidence, time course, and factors associated with cataract formation in bone marrow transplant recipients.

Design: Prospective cohort study.

Setting: University Hospitals, Basel, Switzerland.

Patients: 197 patients treated with allogeneic or autologous bone marrow grafts at least 180 days before the start of the study.

Intervention: Three regimens for bone marrow transplant were used: 74 patients received single-dose, total-body irradiation (TBI), 90 patients received fractionated TBI, and 33 received chemotherapy alone.

Results: Three and one half years after single-dose TBI, 51 of the 74 patients (69%) were alive and cataracts had developed in all of these 51 patients. Cataracts developed in 18 of the 90 (20%) patients treated with fractionated TBI, with an 83% (95% CI, 63% to 100%) risk for lens opacification at 6 years\f. Cataracts developed in only 1 of the 33 (3%) patients treated with chemotherapy alone. Incidence of cataracts is higher and lens opacification occurs earlier after single-dose TBI than after fractionated TBI (P < 0.01). With Cox regression analysis, the use of irradiation (relative risk, 21.0), the mode of irradiation (relative risk, 7.4), and the use of steroid treatment (relative risk, 2.9) for more than 3 months after bone marrow transplantation increased the risk for cataract formation. In contrast, age, sex, and chronic graft-versus-host disease did not influence the rate of cataract development. The probability of requiring cataract surgery after 6 years was 85% (CI, 75% to 95%) for the patients treated with single-dose TBI and 20% (CI, 0% to 49%) for those prepared with fractionated irradiation.

Conclusions: Patients treated with TBI, regardless of fractionation, are likely to have cataracts within 10 years, and some will need surgical repair. Long-term steroid treatment accelerates cataract formation. Preventive measures, such as lens shielding during TBI, should be considered.

Figures

Grahic Jump Location
Figure 1.
The probability of cataract development in 197 patients who were given preparatory single-dose, total-body irradiation, fractionated irradiation, or chemotherapy alone (no irradiation) and then bone marrow transplantation.

TBI = total body irradiation; fTBI = fractionated total body irradiation; STBI = single-dose, total body irradiation.

Grahic Jump Location
Grahic Jump Location
Figure 2.
The probability of requiring cataract surgery in 197 patients who were given preparatory single-dose or fractionated total-body irradiation and then bone marrow transplantation.
Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)